Gastrointestinal Drug Discovery Unit, Takeda Pharmaceuticals
Cosmas is a gastroenterologist physician scientist. He has always been passionate about research starting out at a high young age of 14 with his first research project analyzing the effects of horse farm run-off into local tributaries of his home state of New Jersey. Currently is a Director in the Gastrointestinal (GI) Drug Discovery Unit at Takeda Pharmaceuticals where he focuses on emerging therapeutic modalities from microbiome to regenerative medicine approaches. In addition, to developing strategies for internal drug development programs at Takeda, Cosmas is deeply invested in the biotech community leading external partnerships between Takeda and innovate biotech startups in the GI space. Takeda is one of the largest pharmaceuticals drug companies in world with 231 year history founded in 1781. Prior to joining Takeda, Cosmas was an Assistant Professor of Medicine at Harvard Medical School clinically specializing autoimmune disorders of the gastrointestinal tract including inflammatory bowel disease and celiac disease. Cosmas has been a lead author in prestigious journals such as Cell, Science and Nature related to how cells interpret the human genetic code. He continues to see patients and teach at the Massachusetts General Hospital.
Cosmas was an undergraduate at MIT with a BS in physics. He attended medical school at the University of Medicine and Dentistry of New Jersey and was a Howard Hughes Medical Institute (HHMI) Student scholarship recipient to complete his medical studies. He did his internal medicine residency at Yale and gastroenterology fellowship at Massachusetts General Hospital / Harvard Medical School. He completed trained with post-doctoral training in immunology in the laboratory of HHMI Professor Frederick Alt, PhD. He lives in the Cambridge, MA with his wife Kathleen.